Matches in Wikidata for { <http://www.wikidata.org/entity/Q91458699> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q91458699 description "article scientifique publié en 2019" @default.
- Q91458699 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q91458699 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91458699 description "scientific article published on 01 December 2019" @default.
- Q91458699 description "wetenschappelijk artikel" @default.
- Q91458699 description "наукова стаття, опублікована 1 грудня 2019" @default.
- Q91458699 name "MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B" @default.
- Q91458699 name "MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B" @default.
- Q91458699 type Item @default.
- Q91458699 label "MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B" @default.
- Q91458699 label "MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B" @default.
- Q91458699 prefLabel "MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B" @default.
- Q91458699 prefLabel "MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B" @default.
- Q91458699 P1433 Q91458699-99093133-E7DF-4C6D-A757-7E407134E10A @default.
- Q91458699 P1476 Q91458699-8276CED2-9F10-4EF2-95D3-A60D3C1ED29F @default.
- Q91458699 P275 Q91458699-f5027429-12d5-4ade-9088-8c47ee834494 @default.
- Q91458699 P2860 Q91458699-F1672619-BE79-4AC2-BFEC-12F029B650A6 @default.
- Q91458699 P304 Q91458699-675F7FFF-B281-44A1-8AC4-7CCC1067DEC3 @default.
- Q91458699 P31 Q91458699-85DB585A-AA5C-417E-A222-3805BA0AC32A @default.
- Q91458699 P356 Q91458699-7FC15D3E-82BA-451B-ABB2-5D977AAEE7F8 @default.
- Q91458699 P433 Q91458699-E07C7D9B-5802-4D89-B966-79EFAFD4E9E9 @default.
- Q91458699 P478 Q91458699-08B49A12-2E9E-4F1C-861B-4C4BD066885E @default.
- Q91458699 P50 Q91458699-5F9AEDEB-4272-41A7-94A2-7D09F05E4B08 @default.
- Q91458699 P50 Q91458699-8F2BED0F-C9FC-4828-A9AC-2100599D6D8E @default.
- Q91458699 P50 Q91458699-CAAC4FB0-7584-4A6E-96F8-4DE2D070840D @default.
- Q91458699 P50 Q91458699-FA5D841A-073D-4BAF-8F8D-267BAE1E6368 @default.
- Q91458699 P577 Q91458699-996BE68D-A6DE-481C-B115-7C0ED85470F2 @default.
- Q91458699 P6216 Q91458699-f43b121a-4e99-48e4-a7e9-586649d36ef1 @default.
- Q91458699 P698 Q91458699-F9C49027-EB13-448A-B066-F5696CADBBEE @default.
- Q91458699 P921 Q91458699-551FA1FE-0F8F-41D5-8D80-926E4084FD64 @default.
- Q91458699 P921 Q91458699-D0329557-3924-4B78-AA64-B3132E25E80F @default.
- Q91458699 P932 Q91458699-47E4EDD9-8E1C-422E-80D3-E24D06AD26DF @default.
- Q91458699 P356 YMJ.2019.60.12.1146 @default.
- Q91458699 P698 31769245 @default.
- Q91458699 P1433 Q8055114 @default.
- Q91458699 P1476 "MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B" @default.
- Q91458699 P275 Q34179348 @default.
- Q91458699 P2860 Q58126502 @default.
- Q91458699 P304 "1146-1156" @default.
- Q91458699 P31 Q13442814 @default.
- Q91458699 P356 "10.3349/YMJ.2019.60.12.1146" @default.
- Q91458699 P433 "12" @default.
- Q91458699 P478 "60" @default.
- Q91458699 P50 Q91458689 @default.
- Q91458699 P50 Q91458692 @default.
- Q91458699 P50 Q91458694 @default.
- Q91458699 P50 Q91458697 @default.
- Q91458699 P577 "2019-12-01T00:00:00Z" @default.
- Q91458699 P6216 Q50423863 @default.
- Q91458699 P698 "31769245" @default.
- Q91458699 P921 Q172341 @default.
- Q91458699 P921 Q412415 @default.
- Q91458699 P932 "6881712" @default.